Several signaling pathways (PI3K/AKT/mTORC, MAPK, PI3K/AKT/FOXO) are also involved in the metabolic alteration of cancer cells, which can be targeted to downregulate the metabolic pathways and ultimately inhibit cancer growth and proliferation. Here, AKT1 is linked to cancer.